Clearside Biomedical Inc. (CLSD)
NASDAQ: CLSD
· Real-Time Price · USD
0.79
0.02 (1.94%)
At close: Jun 06, 2025, 3:36 PM
1.94% (1D)
Bid | 0.78 |
Market Cap | 61.62M |
Revenue (ttm) | 1.43M |
Net Income (ttm) | -30.81M |
EPS (ttm) | -0.41 |
PE Ratio (ttm) | -1.93 |
Forward PE | -1.25 |
Analyst | Buy |
Ask | 0.8 |
Volume | 196,589 |
Avg. Volume (20D) | 158,171 |
Open | 0.78 |
Previous Close | 0.78 |
Day's Range | 0.76 - 0.82 |
52-Week Range | 0.70 - 1.65 |
Beta | 2.06 |
About CLSD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CLSD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CLSD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+14.82%
Clearside Biomedical shares are trading higher aft...
Unlock content with
Pro Subscription
11 months ago
+15.74%
Clearside Biomedical shares are trading higher after Oppenheimer initiated coverage with an Outperform rating and a price target of $5.

2 months ago · seekingalpha.com
Clearside Biomedical, Inc. (CLSD) Q4 2024 Earnings Conference Call TranscriptClearside Biomedical, Inc. (NASDAQ:CLSD ) Q4 2024 Earnings Conference Call March 27, 2025 4:30 PM ET Company Participants Jenny Kobin - IR George Lasezkay - CEO Victor Chong - Chief Medical Officer Ch...